Company intelligence / Profile preview
Arrotex Pharmaceuticals
Cremorne, Victoria, Australia
- Ownership
- Private
- Employees
- ~678
- Development stage
- Other
01
Overview
Arrotex Pharmaceuticals is Australia's largest generic and privately owned pharmaceutical company, formed in 2019 from a merger, with over 400 medicines (including approved and widely used generics and some branded drugs), and a broad consumer health catalog
- Therapeutic areas
- OncologyInfectious DiseasesEndocrinology
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Strategic investment partnership with BDT and MSD Partners through parent DBG Health
Beyond the preview
Go deeper on Arrotex Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Arrotex Pharmaceuticals.